-
Product Insights
Graves Diseases Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Graves' disease is an immune system disorder that results in the overproduction of thyroid hormones (hyperthyroidism). Symptoms include anxiety, weight loss, change in menstrual cycles, erectile dysfunction, bulging eyes, and irregular heartbeat. Risk factors include family history, age, autoimmune disorders, smoking, and pregnancy. Treatment includes anti-thyroid medications, beta-blockers, and surgery. The graves diseases pipeline market research report provides comprehensive information on the therapeutics under development for graves diseases, complete with analysis by stage of development, drug target, mechanism of action...
-
Product Insights
Hypoparathyroidism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Hypoparathyroidism is decreased function of the parathyroid glands with underproduction of parathyroid hormone. This leads to low levels of calcium in the blood, often causing cramping and twitching of muscles (involuntary muscle contraction), and several other symptoms. The condition can be inherited, but it is also encountered after thyroid or parathyroid gland surgery, and it can be caused by immune system-related damage as well as a number of rarer causes. The treatment includes artificial form of the hormone that can...
-
Product Insights
Hypothyroidism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Hypothyroidism (underactive thyroid) is a condition in which thyroid gland doesn't produce enough of certain important hormones. Signs and symptom include fatigue, constipation, dry skin, puffy face, muscle weakness, muscle aches, tenderness and stiffness, pain and stiffness. Risk factors include autoimmune diseases, thyroid surgery, radiation therapy and family history of thyroid disease. The Hypothyroidism pipeline drugs market research report provides a comprehensive information on the therapeutics under development for Hypothyroidism, complete with analysis by stage of development, drug target, mechanism...
-
Product Insights
Acromegaly Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
The Acromegaly clinical trial market research report provides an overview of the Acromegaly clinical trials scenario. The report provides top-line data relating to the clinical trials on Acromegaly. The Acromegaly, 2022 report includes an overview of trial numbers and their average enrollment in top countries conducted globally. The clinical trials report also includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status and sponsor type.
-
Product Insights
Acromegaly Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Acromegaly is a hormonal disorder that develops when the pituitary gland produces too much growth hormone during adulthood. Symptoms include body odor, easy fatigue, headache, large feet, excessive height, swelling of the bony areas around a joint, widely spaced teeth, and sleep apnea. Treatment includes surgery, dopamine agonists, and growth hormone antagonists. The Acromegaly pipeline market research report provides comprehensive information on the therapeutics under development for Acromegaly, complete with analysis by stage of development, drug target, mechanism of action...
-
Product Insights
Hypothyroidism Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Hypothyroidism clinical trials market research report provides top line data relating to the clinical trials on hypothyroidism. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials).
-
Product Insights
Endocrine Gland Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Endocrine Gland Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Endocrine Gland Disorders pipeline landscape. The report provides comprehensive information on the therapeutics under development for Endocrine Gland Disorders, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news...
-
Product Insights
Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Congenital Adrenal Hyperplasia (Adrenogenital Syndrome), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research...
-
Product Insights
Idiopathic Short Stature Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Idiopathic Short Stature Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Idiopathic Short Stature pipeline landscape. The report provides comprehensive information on the therapeutics under development for Idiopathic Short Stature, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news...
-
Product Insights
Secondary Hyperparathyroidism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Secondary hyperparathyroidism occurs when the parathyroid glands in the neck produce too much parathyroid hormone (PTH) because calcium levels are too low. Symptoms include bone deformities, broken bones, swollen joints, and chronic kidney failure. Treatment includes calcimimetic and hormone replacement therapy. The Secondary Hyperparathyroidism drugs in development market research report provide comprehensive information on the therapeutics under development for Secondary Hyperparathyroidism, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule...
-
Product Insights
Hyperthyroidism – Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report provides an overview of the hyperthyroidism clinical trials scenario. This report provides top-line data relating to the clinical trials on Hyperthyroidism. The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type. The report also provides prominent drugs for in-progress trials (based on several ongoing...
-
Product Insights
Growth Hormone Deficiency – Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report, “Growth Hormone Deficiency - Global Clinical Trials Review, H2, 2021" provides an overview of Growth Hormone Deficiency Clinical trials scenario. This report provides top line data relating to the clinical trials on Growth Hormone Deficiency. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type....
-
Product Insights
Hyperthyroidism – Global Clinical Trials Review, H1, 2021
GlobalData's clinical trial report, “Hyperthyroidism - Global Clinical Trials Review, H1, 2021" provides an overview of Hyperthyroidism Clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperthyroidism. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for...
-
Product Insights
Growth Hormone Deficiency Disease – Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Growth Hormone Deficiency Global Clinical Trials Review, H2, 2020" provides an overview of Growth Hormone Deficiency Clinical trials scenario. This report provides top line data relating to the clinical trials on Growth Hormone Deficiency. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Hyperthyroidism Disease – Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Hyperthyroidism Global Clinical Trials Review, H2, 2020" provides an overview of Hyperthyroidism Clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperthyroidism. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Graves Diseases Disease – Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Graves Diseases Global Clinical Trials Review, H2, 2020" provides an overview of Graves Diseases Clinical trials scenario. This report provides top line data relating to the clinical trials on Graves Diseases. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Hyperthyroidism Disease – Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Hyperthyroidism Global Clinical Trials Review, H1, 2020" provides an overview of Hyperthyroidism Clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperthyroidism. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Chronic Kidney Disease (Chronic Renal Failure) Disease – Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H1, 2020" provides an overview of Chronic Kidney Disease (Chronic Renal Failure) Clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Kidney Disease (Chronic Renal Failure). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase,...
-
Product Insights
Kidney Disease (Nephropathy) Disease – Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Kidney Disease (Nephropathy) Global Clinical Trials Review, H1, 2020" provides an overview of Kidney Disease (Nephropathy) Clinical trials scenario. This report provides top line data relating to the clinical trials on Kidney Disease (Nephropathy). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Graves Diseases Disease – Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Graves Diseases Global Clinical Trials Review, H1, 2020" provides an overview of Graves Diseases Clinical trials scenario. This report provides top line data relating to the clinical trials on Graves Diseases. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.